Fig. 3From: Naringenin and cryptotanshinone shift the immune response towards Th1 and modulate T regulatory cells via JAK2/STAT3 pathway in breast cancerThe expression of (A) Bcl-XL and (B) Mcl-1 genes, after administration of naringenin (50 mg/kg/day) (Nar) and CPT (20 mg/kg/day) either individually or together (both at the concentration of 20 mg/kg/day). The expression of genes were measured by real-time PCR and analyzed using ÎÎCt method. * Pâ<â0.05, **Pâ<â0.01, Pâ<â0.001, compared to controlBack to article page